Amol Akhade

Amol Akhade Launches Clinician Poll on Adjuvant Therapy for Breast Cancer

Amol Akhade, Senior Consultant Medical Oncologist and Hemato-Oncologist at Suyog Cancer Clinics and Reliance Hospitals, shared a post on X:

“Clinician Poll for ESMOBreast25.

42 y/o woman, post-surgery Breast Cancer:

  • T1cN0M0, ER 5%, PR−, HER2−
  • What’s your approach to adjuvant therapy?
  • Oncotype DX
  • Hormonal therapy or not?
  • Drop your opinion and VOTE below!

Let’s see what the experts say: Yakup Ergün, Erika Hamilton, Sara Tolaney, Hope Rugo, Sarah Sammons, Oncology Brothers.

Would you like me to design a poll layout or graphic to go with it?

  1. Yes for both
  2. No for Both
  3. Yes – oncotype – No -HT
  4. No- Oncotype – Yes -HT.”

More posts featuring Amol Akhade.

Adjuvant Therapy Amol Akhade Breast Cancer Erika Hamilton ESMOBreast25 Hope Rugo MedOnc Oncology Brothers Oncotype Reliance Hospitals Sara Tolaney Sarah Sammons Suyog Cancer Clinics Yakup Ergün